Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology
|
January 1, 1989
Effect of different linkages between chelates and monoclonal antibodies on levels of radioactivity in the liver
S V Deshpande, S J Denardo, C F Meares, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 1, 1992
Pretargeted immunoscintigraphy: effect of hapten valency on murine tumor uptake
D A Goodwin, C F Meares, M McTigue, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 1, 1985
Chelate conjugates of monoclonal antibodies for imaging lymphoid structures in the mouse
D A Goodwin, C F Meares, M J McCall, et al.
Radiation Protection Dosimetry
|
November 15, 2002
Galactic and solar radiation exposure to aircrew during a solar cycle
B J Lewis, L G I Bennett, A R Green, et al.
Cancer Research
|
February 15, 1992
Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy
C Kosmas, D Snook, C S Gooden, et al.
European Journal of Nuclear Medicine
|
January 1, 1986
Metabolizable 111In chelate conjugated anti-idiotype monoclonal antibody for radioimmunodetection of lymphoma in mice
M K Haseman, D A Goodwin, C F Meares, et al.
Cancer Research
|
April 1, 1989
Effect of mass of 111In-benzyl-EDTA monoclonal antibody on hepatic uptake and processing in mice
G P Adams, S J DeNardo, S V Deshpande, et al.
Radiation Protection Dosimetry
|
September 11, 2001
Aircrew exposure from cosmic radiation on commercial airline routes
B J Lewis, M J McCall, A R Green, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 1990
Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent
S V Deshpande, S J DeNardo, D L Kukis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 1, 1988
Copper-67-labeled monoclonal antibody Lym-1, a potential radiopharmaceutical for cancer therapy: labeling and biodistribution in RAJI tumored mice
S V Deshpande, S J DeNardo, C F Meares, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology
|
January 1, 1989
Effect of different linkages between chelates and monoclonal antibodies on levels of radioactivity in the liver
S V Deshpande, S J Denardo, C F Meares, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 1, 1992
Pretargeted immunoscintigraphy: effect of hapten valency on murine tumor uptake
D A Goodwin, C F Meares, M McTigue, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 1, 1985
Chelate conjugates of monoclonal antibodies for imaging lymphoid structures in the mouse
D A Goodwin, C F Meares, M J McCall, et al.
Radiation Protection Dosimetry
|
November 15, 2002
Galactic and solar radiation exposure to aircrew during a solar cycle
B J Lewis, L G I Bennett, A R Green, et al.
Cancer Research
|
February 15, 1992
Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy
C Kosmas, D Snook, C S Gooden, et al.
European Journal of Nuclear Medicine
|
January 1, 1986
Metabolizable 111In chelate conjugated anti-idiotype monoclonal antibody for radioimmunodetection of lymphoma in mice
M K Haseman, D A Goodwin, C F Meares, et al.
Cancer Research
|
April 1, 1989
Effect of mass of 111In-benzyl-EDTA monoclonal antibody on hepatic uptake and processing in mice
G P Adams, S J DeNardo, S V Deshpande, et al.
Radiation Protection Dosimetry
|
September 11, 2001
Aircrew exposure from cosmic radiation on commercial airline routes
B J Lewis, M J McCall, A R Green, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 1990
Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent
S V Deshpande, S J DeNardo, D L Kukis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 1, 1988
Copper-67-labeled monoclonal antibody Lym-1, a potential radiopharmaceutical for cancer therapy: labeling and biodistribution in RAJI tumored mice
S V Deshpande, S J DeNardo, C F Meares, et al.
Page
of 5